Paramount’s directors are expected to review the new offer, which is more favorable to both Paramount’s voting and nonvoting shareholders.
![](https://immunet.online/wp-content/uploads/2024/05/medium-7zxvX5.jpeg)
Paramount’s directors are expected to review the new offer, which is more favorable to both Paramount’s voting and nonvoting shareholders.